- Patients who failed to an approved treatment which can be EPO, lenalidomide or Vidaza® or who are not eligible for such a treatment or who have thrombocytopenia < 20 G/L requiring transfusion or neutropenia < 0.5 G/L associated with severe infection (defined as requiring hospitalization)